The Uk Medicines And Healthcare Products Regulatory Agency (Mhra) Has Approved Another Covid-19 Treatment Xevudy (Sotrovimab) After It Was Found To Be Safe And Effective At Reducing The Risk Of Hospitalisation And Death In People With Mild To Moderate Covid-19 Infection Who Are At An Increased Risk Of Developing Severe Disease.This Approval Follows A Rigorous Review Of Its Safety, Quality And Effectiveness By The Uk Regulator And The Government
